Smith & Nephew plc (LON:SN) Given Average Recommendation of “Hold” by Brokerages
Smith & Nephew plc (LON:SN) has earned a consensus recommendation of “Hold” from the fourteen brokerages that are currently covering the firm. Nine equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is GBX 1,308.18 ($17.08).
A number of equities analysts have issued reports on SN shares. JPMorgan Chase & Co. restated a “neutral” rating and issued a GBX 1,199 ($15.65) price objective on shares of Smith & Nephew plc in a research report on Wednesday, September 14th. Jefferies Group boosted their price objective on shares of Smith & Nephew plc from GBX 1,375 ($17.95) to GBX 1,420 ($18.54) and gave the company a “buy” rating in a research report on Thursday, June 30th. Goldman Sachs Group Inc. restated a “buy” rating on shares of Smith & Nephew plc in a research report on Tuesday, September 13th. BNP Paribas restated an “outperform” rating and issued a GBX 1,335 ($17.43) price objective on shares of Smith & Nephew plc in a research report on Monday, June 27th. Finally, Numis Securities Ltd restated an “add” rating and issued a GBX 1,242 ($16.21) price objective on shares of Smith & Nephew plc in a research report on Friday, June 24th.
Shares of Smith & Nephew plc (LON:SN) traded up 0.97% during trading on Wednesday, reaching GBX 1252.00. 1,561,673 shares of the company traded hands. The firm’s 50 day moving average is GBX 1,244.89 and its 200-day moving average is GBX 1,202.77. Smith & Nephew plc has a 12-month low of GBX 1,040.36 and a 12-month high of GBX 1,324.00. The stock’s market capitalization is GBX 11.19 billion.
In other news, insider Bottomley ,Virginia bought 238 shares of the company’s stock in a transaction dated Monday, August 15th. The shares were purchased at an average price of GBX 1,290 ($16.84) per share, for a total transaction of £3,070.20 ($4,007.57).
Smith & Nephew plc Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.
Receive News & Stock Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related stocks with our FREE daily email newsletter.